Infectious diseases don't wait.
Neither do we

We protect children's futures from pregnancy through
adolescence with equitable science

Get to know us


Penta is an international independent scientific network dedicated to child health. Our work is the result of a passionate collaboration between healthcare professionals and researchers in 124 clinical sites and 26 cohorts across 27 countries around the world.

Through our studies and partnerships, we develop and deliver world-class research and training in paediatric infectious diseases to improve the lives of women and children, wherever they live.

Are you interested joining the Penta ID Network? Complete this form to apply.

Meet the 2026 Penta Brighter Future Award (BFA) winners!

This prestigious biennial award recognises visionary leaders dedicated to dismantling health inequities in maternal and child infectious diseases, specifically targeting HIV, tuberculosis (TB), vaccine access and the fortification of fragile health systems.

Penta Strategy 2025-2029: building on progress, driving strategic impact

Building on the results of our previous strategy, Penta’s 2025-2029 Strategic Plan focuses on accelerating scientific impact through high-quality research and strategic partnerships, especially in regions with the greatest need.

Penta advocates for equitable access to healthcare across all activities and strives to engage with affected and at-risk communities to maximise impact.

 

Current Penta studies around the World



Always expanding

Penta continues to grow, bringing together healthcare professionals, researchers and scientists worldwide to address a wide range of healthcare issues.
0

Members

0

Countries

0

Years of activity

0

Ongoing studies and projects

Previous

Latest News

Next

Empowerment, inspiration, and adaptation: My time at the Annual CHIVA Conference

13 Apr, 2026

This article was written by Penta Young Reporter, Arlene. Find out more about the Penta Young Reporters here. What is CHIVA?
Read More

Young people living with HIV should take their HIV medicines daily, according to the BREATHER+ trial

09 Apr, 2026

This article was originally published in the UCL Innovative Clinical Trials Unit website. Penta contributed to BREATHER+ by coordinating youth involvement through its Youth Trial Boards.
Read More

ENABLE project launches to evaluate enhancement of treatment of HIV in infants by adding monoclonal antibodies

27 Mar, 2026

Funded by Global Health EDCTP3 and the European Union, the project brings together 21 partners across Africa, Europe and the United States to improve early HIV treatment outcomes in infants.
Read More

How can we end TB in children if we can’t find it?

24 Mar, 2026

When we think of Tuberculosis (TB), we often picture an adult with a persistent cough. But there is another side that is often left in the shadows, the children who…
Read More

The impact of Penta’s Youth Trial Boards

20 Mar, 2026

Involving young people in clinical research might feel like a leap into the unknown for many researchers, but Penta’s experience shows that it is one of the most rewarding ways…
Read More

Keep up to date with the latest Penta news

Sign up to receive our monthly Penta Newsletter filled with the latest news on our studies, projects and people